|
| 36479637 | Biomarkers predictive of response to pembrolizumab in head and neck cancer. | Cancer Med | 2023 |
| 37643133 | A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma. | Clin Cancer Res | 2023 |
| 37212448 | A prospective evaluation of neck and shoulder function following treatments of early-stage human papillomavirus-associated oropharynx cancer. | Clin Otolaryngol | 2023 |
| 35171659 | Real-World Experience of <i>NTRK</i> Fusion-Positive Thyroid Cancer. | JCO Precis Oncol | 2022 |
| 35556126 | Non-Iodine-Avid Disease Is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer With Papillary Histology. | J Clin Endocrinol Metab | 2022 |
| 36428790 | Approaches to the Management of Metastatic Adenoid Cystic Carcinoma. | Cancers (Basel) | 2022 |
| 36108661 | Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. | Lancet Oncol | 2022 |
| 35867947 | Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). | J Clin Oncol | 2022 |
| 36053203 | Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. | J Natl Cancer Inst | 2022 |
| 35217573 | Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma. | J Immunother Cancer | 2022 |
| 32883697 | CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus-Associated Head and Neck Cancers. | Mol Cancer Res | 2021 |
| 34735757 | Effect of chemotherapy and radiotherapy on cognitive impairment in colorectal cancer: evidence from Korean National Health Insurance Database Cohort. | Epidemiol Health | 2021 |
| 34779417 | Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma. | J Clin Invest | 2021 |
| 34568721 | Ovarian Failure Preceding Head and Neck Squamous Cell Carcinoma Identifies an Adult-Onset Cancer-Prone Syndrome Caused by <i>FANCM</i> Mutations. | JCO Precis Oncol | 2021 |
| 34045293 | Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes. | Clin Cancer Res | 2021 |
| 34024488 | Molecular Markers that Matter in Salivary Malignancy. | Otolaryngol Clin North Am | 2021 |
| 33408119 | Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma. | Cancer Res | 2021 |
| 32846061 | Efficacy of Selpercatinib in <i>RET</i>-Altered Thyroid Cancers. | N Engl J Med | 2020 |
| 32663913 | Squamous cell carcinoma of head and neck: what internists should know. | Korean J Intern Med | 2020 |
| 32792211 | The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma. | Oral Oncol | 2020 |
| 30373905 | Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy. | Oncologist | 2019 |
| 30726685 | More on Mu-Opioid Receptor Antagonists in PD-1 Blockade-Induced Pruritus. | N Engl J Med | 2019 |
| 30297384 | Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1-Deficient Carcinoma. | Oncologist | 2019 |
| 28685830 | Treatment, short-term outcomes, and costs associated with larynx cancer care in commercially insured patients. | Laryngoscope | 2018 |
| 30122219 | Detection of AR-V7 transcript with RNA in situ hybridization in human salivary duct cancer. | Oral Oncol | 2018 |
| 30121970 | Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the United States veterans with prostate cancer. | Epidemiol Health | 2018 |
| 29955135 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012. | Br J Cancer | 2018 |
| 30170629 | Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas. | J Immunother Cancer | 2018 |
| 31093356 | Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC). | Cancers Head Neck | 2018 |
| 31093355 | Response to R-CHOP in HPV-related squamous cell carcinoma of base of tongue: a case report. | Cancers Head Neck | 2018 |
| 30421818 | Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States. | Head Neck | 2018 |
| 30478962 | Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas. | Head Neck | 2018 |
| 30332571 | PD-1 Blockade-Induced Pruritus Treated with a Mu-Opioid Receptor Antagonist. | N Engl J Med | 2018 |
| 29573418 | Short- and long-term outcomes of oropharyngeal cancer care in the elderly. | Laryngoscope | 2018 |
| 29743117 | A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report. | J Immunother Cancer | 2018 |
| 29683815 | Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity. | Am J Surg Pathol | 2018 |
| 28988469 | Treatment, survival, and costs of oropharyngeal cancer care in the elderly. | Laryngoscope | 2018 |
| 29243261 | Quality indicators of oropharyngeal cancer care in the elderly. | Laryngoscope | 2018 |
| 27340278 | Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma. | Clin Cancer Res | 2017 |
| 30003184 | Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board. | JCO Precis Oncol | 2017 |
| 28328302 | Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study. | J Clin Oncol | 2017 |
| 29103750 | Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy. | Oral Oncol | 2017 |
| 29340028 | High-resolution microbiome profiling uncovers <i>Fusobacterium nucleatum</i>, <i>Lactobacillus gasseri/johnsonii</i>, and <i>Lactobacillus vaginalis</i> associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation. | Oncotarget | 2017 |
| 28812214 | The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma. | Cancer Metastasis Rev | 2017 |
| 28688188 | Quality indicators of laryngeal cancer care in commercially insured patients. | Laryngoscope | 2017 |
| 28522603 | SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells. | Clin Cancer Res | 2017 |
| 28055120 | Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma. | Cancer | 2017 |
| 27930766 | Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method. | JAMA Oncol | 2017 |
| 28031159 | Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. | Cancer Discov | 2017 |
| 26999264 | FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy. | AJR Am J Roentgenol | 2016 |